Arch Therapeutics, Inc.: auditor change — Arch Therapeutics files Chapter 11, expects no shareholder recovery; stalking horse bid from Vivex Biologics

Arch Therapeutics, Inc.

Filed Chapter 11 on April 18, 2025; stalking horse bid by Vivex Biologics for substantially all assets.
Court approved bidding procedures; sale hearing set for June 20, 2025. DIP credit bid up to $900K.
Prepetition secured parties to receive $500K carve-out; anticipated no recovery for shareholders.
Auditor Weinberg resigned May 22, 2025; company non-compliant with SEC filings since Sep 2024 10-K.
Securities moved to OTC Expert Market (ARTHQ); board reduced to two members, single officer.

item 1.03 item 2.04 item 3.01 item 4.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Weinberg & Company, P.A. resigned as auditor of Arch Therapeutics, Inc..

Action: resignation
Auditor: Weinberg & Company, P.A.

Exact text from the filing

On May 22, 2025, Weinberg & Company, P.A. (“Weinberg”) notified the Company of its resignation as the independent registered public accounting firm for the Company, effective immediately.

View on SEC.gov

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

Arch Therapeutics, Inc. entered chapter 11 in United States Bankruptcy Court, District of Massachusetts (Worcester) (petition 2025-04-18).

Proceeding: chapter 11
Court: United States Bankruptcy Court, District of Massachusetts (Worcester)
Petition: 2025-04-18

Exact text from the filing

On April 18, 2025, Arch Therapeutics, Inc. (the "Company" or "Arch Therapeutics, Inc.") and its fully owned subsidiary, Arch Biosurgery, Inc., filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court, District of Massachusetts (Worcester) (the "Court"), case 25-40409.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

Source: SEC EDGAR

accession 0001641172-25-012288

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.